Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: A European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group study

Journal of Clinical Oncology

Volumn 15, Issue 8, 1997, Pages 2840-2849

  Gregor, Anna ^a   Drings, Peter ^a   Burghouts, Jos ^a   Postmus, Piet E ^a   Morgan, David ^a   Sahmoud, Tarek ^a   Kirkpatrick, Ann ^a   Dalesio, Otilia ^a   Giaccone, Giuseppe ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGITIS; EUROPE; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SURVIVAL RATE; THROMBOCYTOPENIA; VOMITING;

EID: 0030792988     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.8.2840     Document Type: Article

References (45)

1. Pignon JP, Arriagada R, Ihde D, et al: A meta-analysis of thoracic radiotherapy for small cell lung cancer. N Engl J Med 327:1618-1624, 1992
2. Looney WB, Hopkins HA: Alteration of chemotherapy and radiotherapy in cancer management III. Results in experimental solid tumour systems and their relationship to clinical studies. Cancer Treat Rep 70:141-62, 1986
3. Steel GG, Peckham MJ: Exploitable mechanisms in combined radiotherapy chemotherapy: The concept of additivity. Int J Radiat Oncol Biol Phys 5:85-91, 1979
4. Tubiana M, Arriagada R, Cossett JM: Sequencing of drugs and radiation. The integrated alternating regimen. Cancer 55:2131-2139, 1985
5. Arriagada R, Le Chevalier T, Baldeyrou P, et al: Alternating radiotherapy and chemotherapy schedules in small cell lung cancer limited disease. Int J Radiat Oncol Biol Phys 11:1461-1467, 1985
6. Arriagada R, Le Chevalier T, Ruffie P, et al: Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Centre's Lung Group. Int J Radiat Oncol Biol Phys 19:1135-1138, 1990
7. Giaccone G, Dalesio O, McVie GJ, et al: Maintenance chemotherapy in small-cell lung cancer: Long-term results of a randomized trial. EORTC Lung Cancer Cooperative Group. J Clia Oncol 11:1230-1240, 1993
8. Coy P, Hodson I, Payne D, et al: The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys 14:219-226, 1988
9. Turrisi AT, Glover D: Thoracic radiotherapy variables: Influence on local control in small cell lung cancer. Int J Radiat Oncol Biol Phys 19:1473-1479, 1990
10. Gregor A, Drings P, Rinaldi M, et al: Acute toxicity of alternating schedule of chemotherapy and irradiation in limited small-cell lung cancer in a pilot study (08877) of the EORTC Lung Cancer Cooperative Group. Ann Oncol 6:403-405, 1995 (letter)
11. Pocock SJ, Simon R: Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31:103-115, 1975
12. Freedman LS: Tables of the number of patients required in clinical trials using the logrank test. Stat Med 1:121-129, 1982
13. Dupont WD, Plummer WD Jr: Power and sample size calculations. A review and computer program. Control Clin Trials. 11:116-128, 1990
14. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
15. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
16. Cox GM: The Biometric Society, the first twenty-five years (1947-1972). Biometrics 28:285-311, 1972
17. Gregor A, Cull A, Stephens RJ, et al: Prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC): Results of UKCCCR/EORTC randomised trial. Proc Am Soc Clin Oncol 15:381, 1996 (abstr 1139)
18. WHO: Handbook for Reporting Results of Cancer Treatment. Who Offset Publication. No. 48. Geneva, Switzerland, World Health Organization, 1979
19. Goldie JH, Coldman AJ: The genetic origin of drug resistance in neoplasm implications for systemic therapy. Cancer Res 44: 3643-3653, 1984
20. Brooks BJ Jr, Seifter EJ, Walsh TE, et al: Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer. J Clin Oncol 4:200-209, 1986
21. Bunn PA, Lichter AS, Makuch RW, et al: Chemotherapy alone or chemotherapy with chest irradiation therapy in limited stage small cell lung cancer: A prospective randomised trial. Ann Intern Med 106:655-662, 1987
22. McCracken JD, Janaki LM, Crowley JJ, et al: Concurrent chemotherapy/ radiotherapy for limited small-cell lung carcinoma: A Southwest Oncology Group study. J Clin Oncol 8:892-898, 1990
23. Murray N, Coy P, Pater J, et al: Importance of timing for thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer. J Clin Oncol 11:336-344, 1991
24. Parsons JT, Bova FJ, Million RR: A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 6:1645-1652, 1980
25. Bleehen NM, Girling DJ, Gregor A, et al: A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party. Br J Cancer 64:775-779, 1991
26. Gregor A: Factors influencing use of alternating chemotherapy and radiation schedules in small cell lung cancer. Lung Cancer 10:S299-305, 1994 (suppl 1)
27. Feld R: Complications in the treatment of small cell carcinoma of the lung. Cancer Treat Rev 8:5-25, 1981
28. Hoskin PJ, Partin D, Yarnold JR, et al: Intercalated radiochemotherapy in small cell lung cancer toxicity and implications for future regimens. Radiother Oncol 20:177-180, 1991
29. Arriagada R, Kramar A, Le Chevalier T, et al: Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centres' Lung Group. J Clin Oncol 10:447-451, 1992
30. Perez CA, Einhorn L, Oldham RK, et al: Randomized trial of radiotherapy to the thorax in limited small cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: A preliminary report. J Clin Oncol 2:1200-1208, 1984
31. Kies MS, Mira JC, Livingston RB: Multimodal therapy for limited small cell lung cancer. A randomized study of induction combination chemotherapy with or without thoracic irradiation in complete responders, and with widefield versus reduced volume radiation in partial responders. J Clin Oncol 5:592-600, 1987
32. Warde P, Payne D: Does thoracic irradiation improve survival and local control in limited-stage small cell carcinoma of the lung? J Clin Oncol 6:890-895, 1992
33. Coy P, Hodson I, Murray N, et al: Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys 28:355-362, 1993
34. Liengswangwong JA, Bonner EG, Shaw RL, et al: Limited stage small cell lung cancer: Patterns of intrathoracic recurrence and the implications of thoracic radiotherapy. J Clin Oncol 12:496-502, 1994
35. Turrisi AT: Thoracic radiotherapy variables: Influence on local control in small cell lung cancer limited disease. Int J Radiat Oncol Biol Phys 19:1473-1479, 1990
36. Payne DG: The role of thoracic irradiation therapy in small cell carcinoma of the lung: A consensus report. Lung Cancer 5:135-138, 1989
37. Carmichael J, Degraff WG, Gamson J, et al: Radiation sensitivity of human lung cancer cell lines. Eur J Cancer 25:527-534, 1989
38. Carney DN, Mitchell JB, Kinsella TJ: In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants. Cancer Res 43:2806-2811, 1983
39. Duchesne G, Cassoni A, Pera M: Radiosensitivity related to neuroendocrine and endodermal differentiation in lung carcinoma lines. Radiother Oncol 13:153-161, 1988
40. Turrisi AT, Glover DJ, Mason B, et al: Long term results of platinum etoposide and twice daily thoracic radiotherapy for limited small cell lung cancer. Proc Am Soc Clin Oncol 11:292, 1992 (abstr)
41. Frytak S, Shaw E, Eagan R, et al: Accelerated, hyperfractionated split course thoracic radiotherapy and infusion cisplatin based chemotherapy for small cell lung cancer. Lung Cancer 7:157, 1991 (suppl)
42. Sause WT, Scott C, Taylor S, et al: RTOG 8808 and ECOG 4588: Preliminary results of a phase II trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst 87:198-205, 1995
43. Johnston BE, Salen C, Nesbitt J, et al: Limited stage small cell lung cancer treated with concurrent hyperfractionated chest radiotherapy etoposide/cisplatin. Lung Cancer 9:215-265, 1993
44. Roach M, Gandara DR, Hae-Sook Y, et al: Radiation pneumonitis following combined modality therapy for lung cancer: Analysis of prognostic factors. J Clin Oncol 13:2606-2612, 1995
45. Schaake-Koning C, van den Bogaert W, Dalesio O, et al: Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Eng J Med 326:524-530, 1992